Drug treatment of asymptomatic hypertriglyceridemia has long been controversial. In the absence of evidence that drug treatment of moderate hypertriglyceridemia reduces vascular events,guidelines have stopped short of recommending it. However,unproven hypotheses that triglyceride levels of 500 mg/dL or greater (≥5.65 mmol/L) carry a substantial risk for pancreatitis in asymptomatic persons and that drugs [...]